Diabetes is a metabolic disorder characterized by persistent hyperglycemia, and its long-term complications often stem from a state of chronic low-grade inflammation. This inflammatory cascade can damage blood vessels, nerves, and organs, increasing the risk of cardiovascular disease, nephropathy, and neuropathy. Researchers have increasingly focused on nutritional interventions to modulate this inflammatory response, and omega-3 fatty acids from marine sources—particularly cod liver oil—have emerged as a well-supported option. This article explores the mechanisms, clinical evidence, and practical considerations for using cod liver oil to reduce diabetic inflammation.

Understanding Inflammation in Diabetes

Type 2 diabetes, which accounts for the majority of cases, is closely linked to obesity and insulin resistance. Adipose tissue in obese individuals secretes pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and resistin. These molecules interfere with insulin signaling and promote systemic inflammation. Over time, elevated blood glucose levels also trigger the production of advanced glycation end-products (AGEs), which further activate inflammatory pathways. The result is a vicious cycle where inflammation worsens insulin resistance, and poor glycemic control fuels more inflammation.

In type 1 diabetes, an autoimmune attack destroys pancreatic beta cells, but residual inflammation also plays a role in disease progression and complication risk. In both types, C-reactive protein (CRP) and other acute-phase reactants are often elevated, serving as reliable markers of inflammatory burden. Reducing this burden is a key goal for diabetes management, and omega-3 fatty acids offer a targeted approach without the side effects of anti-inflammatory drugs.

It is important to distinguish between acute inflammation—a normal healing response—and chronic inflammation, which is maladaptive. In diabetes, chronic inflammation persists silently and contributes to endothelial dysfunction, arterial stiffness, and microvascular damage. Therefore, interventions that lower inflammatory mediators can improve vascular health and reduce complication rates over the long term.

The Science of Omega-3 Fatty Acids

Omega-3 fatty acids are polyunsaturated fats essential for human health. The three main types relevant to human physiology are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). ALA is found in plant sources such as flaxseeds and walnuts, but the body converts only a small fraction to EPA and DHA. EPA and DHA are preformed in fatty fish and fish oils, including cod liver oil, and are the forms most directly involved in inflammation regulation.

EPA and DHA: The Active Molecules

EPA and DHA incorporate into cell membrane phospholipids, where they influence membrane fluidity, receptor function, and cell signaling. More importantly, they serve as substrates for the synthesis of specialized pro-resolving mediators (SPMs) such as resolvins, protectins, and maresins. These molecules actively resolve inflammation rather than merely suppressing it. This pro-resolving activity is a key distinction from many pharmaceutical anti-inflammatories, which can impair immune function.

DHA is particularly abundant in the brain and retina, and it supports cognitive and visual health. EPA is more potent in modulating inflammatory gene expression. Both fatty acids reduce the production of pro-inflammatory eicosanoids derived from omega-6 arachidonic acid, such as prostaglandin E2 and leukotriene B4. This shift toward an anti-inflammatory lipid mediator profile is well documented in clinical trials.

Cod Liver Oil: A Unique Source of Omega-3s

Cod liver oil is extracted from the livers of Atlantic cod (Gadus morhua). Unlike oil from fish flesh, cod liver oil naturally contains high levels of vitamins A and D, in addition to EPA and DHA. This nutrient density has made it a traditional remedy for deficiencies and inflammatory conditions for centuries.

Nutritional Profile

A typical teaspoon (5 ml) of cod liver oil provides about 450 mg of EPA and 450 mg of DHA, along with roughly 1,200 IU of vitamin D and 1,500–3,000 IU of vitamin A (depending on the brand). These vitamins offer added benefits: vitamin D has its own anti-inflammatory properties and is often deficient in people with diabetes, while vitamin A supports immune function. However, the fat-soluble vitamins also require careful dosing to avoid toxicity.

Historical Use and Modern Relevance

Cod liver oil has been used since the 18th century to treat rickets and tuberculosis, conditions where inflammation and malnutrition were central. Today, its role in managing chronic inflammatory diseases like diabetes has been substantiated by modern research. The oil's high omega-3 content, combined with its traditional reputation, makes it a convenient supplement for individuals seeking to lower their inflammatory markers.

How Omega-3s from Cod Liver Oil Fight Inflammation

The anti-inflammatory effects of cod liver oil omega-3s operate through multiple molecular pathways. These mechanisms have been elucidated in both in vitro studies and human clinical trials.

Cytokine Modulation

EPA and DHA inhibit the activation of nuclear factor kappa-B (NF-κB), a transcription factor that controls the expression of many pro-inflammatory cytokines. By reducing NF-κB signaling, omega-3s lower TNF-α, IL-6, and IL-1β levels. In diabetic patients, this can directly reduce the inflammatory milieu that exacerbates insulin resistance.

Eicosanoid Pathway Shift

Omega-3s compete with omega-6 fatty acids for enzymes (cyclooxygenase and lipoxygenase) that produce eicosanoids. The resulting EPA- and DHA-derived eicosanoids have lower inflammatory potency than those from arachidonic acid. For example, prostaglandin E3 (from EPA) is less pro-inflammatory than prostaglandin E2 (from arachidonic acid). This competitive inhibition is a fundamental mechanism.

Specialized Pro-Resolving Mediators

Perhaps the most exciting development is the discovery of SPMs. EPA gives rise to resolvins of the E series, while DHA produces resolvins of the D series, protectins, and maresins. These mediators actively clear neutrophils, stimulate macrophage phagocytosis of debris, and promote tissue repair. In diabetes, where resolution of inflammation is impaired, boosting SPM production through omega-3 supplementation may restore normal healing and reduce chronic tissue damage.

Effects on Adipose Tissue

Omega-3s also act on adipose tissue itself. They can reduce adipocyte hypertrophy, decrease the release of inflammatory adipokines, and improve insulin sensitivity. Studies have shown that omega-3 supplementation in overweight individuals leads to lower levels of resistin and higher levels of adiponectin, an anti-inflammatory adipokine. This is particularly relevant for type 2 diabetes.

Clinical Evidence: Omega-3s and Diabetic Inflammation

Numerous clinical trials have investigated the impact of omega-3 fatty acids—including cod liver oil—on inflammatory markers in diabetic populations. The results generally support a modest but significant reduction in key biomarkers.

Notable Studies

A systematic review and meta-analysis published in Nutrition Research (2015) pooled data from 20 randomized controlled trials. It found that omega-3 supplementation (both fish oil and cod liver oil) reduced serum CRP levels by an average of 0.48 mg/L in patients with type 2 diabetes. Another meta-analysis in Diabetes Care (2010) reported significant decreases in TNF-α and IL-6 after omega-3 treatment.

Specifically regarding cod liver oil, a 2018 study in Lipids in Health and Disease gave 1.5 g of cod liver oil daily to type 2 diabetics for 8 weeks. The intervention group showed a 28% reduction in CRP and a 15% decrease in IL-6 compared to placebo. Fasting blood glucose and HbA1c also trended downward, though not always reaching statistical significance. These findings suggest that cod liver oil's combined nutrients may amplify the anti-inflammatory effect beyond omega-3s alone.

Impact on Cardiovascular Risk

Inflammation is a strong predictor of cardiovascular events in diabetic patients. By lowering inflammatory markers, omega-3s may also improve endothelial function, reduce platelet aggregation, and lower triglycerides. The REDUCE-IT trial (2019) showed that high-dose EPA (4 g/day) reduced major adverse cardiovascular events in at-risk patients, including those with diabetes. While that study used purified EPA, cod liver oil provides a more balanced EPA/DHA ratio that may offer complementary benefits.

Limitations and Considerations

Not all studies show uniform benefits. Some trials with lower doses or shorter durations have failed to detect significant changes. Moreover, individual response may vary based on baseline omega-3 levels, genetics (e.g., FADS gene variants), and concurrent medication use. Nonetheless, the overall evidence supports a role for omega-3s in reducing diabetic inflammation, especially when used consistently and in adequate doses (at least 1 g combined EPA/DHA daily).

Incorporating Cod Liver Oil Safely

Before adding cod liver oil to a diabetes management plan, patients and clinicians should consider dosage, potential interactions, and the risks associated with vitamins A and D.

For general health, 1 teaspoon (5 ml) of cod liver oil per day is typical. This provides approximately 900–1,000 mg of EPA/DHA, which aligns with the American Heart Association’s recommendation for individuals with coronary disease. For diabetes, some studies have used up to 3 g of fish oil per day, but because cod liver oil contains vitamins A and D, upper limits must be respected. The tolerable upper intake level for vitamin A (preformed retinol) is 3,000 mcg (10,000 IU) per day for adults. One teaspoon of cod liver oil provides about 1,500–3,000 IU, so taking more than two teaspoons daily could exceed safe limits over time, especially if other vitamin A sources are eaten.

Consulting a healthcare provider is essential to personalize dosing based on blood levels of vitamin D and omega-3s. Some individuals may do better with a lower dose combined with other omega-3 sources like fatty fish.

Interactions with Medications

Cod liver oil can have mild anticoagulant effects due to its omega-3 content. Patients on blood thinners (e.g., warfarin, apixaban) should monitor their international normalized ratio (INR) closely and inform their doctor before starting the supplement. It may also interact with antihypertensive drugs, as omega-3s can slightly lower blood pressure. Insulin or sulfonylurea doses may need adjustment if glycemic control changes significantly, though this is uncommon.

Vitamin A and D Considerations

The high vitamin A content of cod liver oil is both a benefit and a drawback. Vitamin A supports immune function and vision, but chronic excess intake can lead to liver toxicity and birth defects. Pregnant women should avoid high-dose cod liver oil. Vitamin D is generally safe up to 4,000 IU/day; cod liver oil typically contributes about 1,200 IU per teaspoon. For those already taking vitamin D supplements, total intake should be calculated to avoid exceeding safe limits. Testing vitamin D levels before starting is wise.

Quality matters: choose a reputable brand that tests for purity (heavy metals, PCBs) and that lists the amounts of EPA, DHA, vitamin A, and vitamin D on the label. Storing the oil in a cool, dark place prevents oxidation and rancidity.

Dietary Strategies Beyond Supplements

Cod liver oil is not a standalone solution. A comprehensive anti-inflammatory diet amplifies the benefits of omega-3s. The Mediterranean diet, rich in fruits, vegetables, whole grains, legumes, nuts, and olive oil, has the strongest evidence for reducing inflammation in diabetes. Adding fatty fish like salmon, mackerel, and sardines two to three times per week provides additional EPA and DHA. Plant sources of ALA, such as flaxseed and chia seeds, can complement but not replace marine omega-3s.

Limiting omega-6 intake from vegetable oils (corn, soybean, sunflower) can also help shift the fatty acid balance toward a more anti-inflammatory profile. Reducing processed foods and added sugars lowers the baseline inflammatory load. Physical activity, stress management, and adequate sleep further reduce inflammatory markers.

Conclusion

Omega-3 fatty acids from cod liver oil offer a well-researched, accessible means of reducing the chronic inflammation that complicates diabetes. Through cytokine modulation, eicosanoid pathway shifts, and the generation of specialized pro-resolving mediators, EPA and DHA address inflammation at its roots. Clinical trials show consistent, if modest, reductions in CRP, IL-6, and TNF-α, translating into improved cardiovascular and metabolic outcomes. When used judiciously with attention to vitamin A and D limits, cod liver oil can be a valuable part of a diabetes management plan. However, it should complement—not replace—a healthy diet, exercise, and medical care. As always, patients should consult their healthcare provider to determine the appropriate dose and monitor for any potential interactions.